The SUSTAIN-6 trial showed that Ozempic reduced the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) in patients with type 2 diabetes at high cardiovascular risk
J Biotechnol 374:516
Available online at: (Accessed May 9, 2025)
A dose-response analysis across 39 randomised trials and 33,354 participants found that nausea risk rose fastest across the lowest doses, then showed a tendency to plateauing at highest dosages
Methods This retrospective cohort study emulating a target trial included patient data from the multi-institutional Chang Gung Research Database in Taiwan
Individual personal injury actions, however, may be a better option for patients who have suffered severe or unique injuries, as these cases can seek compensation tailored to their medical expenses, lost income, and long-term care needs